semaglutide and kidney disease Long-term outcomes of in obesity cardiovascular in the SELECT trial FLOW Study Highlights: How Semaglutide

PMID 24912947

First Generation | Liraglutide Liraglutide was the first version of GLP-1 medications for weight loss and type 2 diabetes

Get this right and everything else becomes substantially easier

In the Phase 2 trial published in the New England Journal of Medicine in 2023 (Jastreboff et al.), participants on the highest dose lost an average of about 24.2 percent of their body weight at 48 weeks, compared with roughly 2 percent on placebo

In perhaps the most well-known compounding disaster , contaminated injectable steroids made in unsafe conditions by a compounding pharmacy in Massachusetts killed at least 60 people and sickened more than 700 in 2012